arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

NRC HEALTH

NRC
$21.58 ▼ -0.32 (-1.46%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
68 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

NRC HEALTH shows mixed fundamentals. However, watch Debt to Equity which shows concerning trends. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap $475.0M
Dividend Yield 0.74%
Revenue Growth 4.0% ↗
Op. Margin -9.1% ↘
ROIC -2.5% ↘
FCF / Share $0.00 ↘
Trailing P/E —
Price / Book 73.0x
FCF Yield 0.0%
Debt / Equity 13.13
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$35.39M
↑ +4.0% —
Net Income Profit after all expenses
$3.22M
↓ -44.3% —
Operating Margin Operating profit as % of sales
-9.1%
↓ -157.2% 70th
FCF / Share Free cash flow per share
$0.00
↓ -98.9% —
Long-Term Debt Long-term obligations
$86.01M
↑ +16.2% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↓
65
Returns ↑
99
Financial Health →
39
Cash Quality ↑
77

Dividend History

Dividend / share · sourced from SEC filings
$0.52 Latest / share
+8.3% YoY
+19.9% 6-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters